Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Free Cash Flow: 2019-2024

Historic Free Cash Flow for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to -$131.8 million.

  • Praxis Precision Medicines' Free Cash Flow fell 136.54% to -$65.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$228.9 million, marking a year-over-year decrease of 130.08%. This contributed to the annual value of -$131.8 million for FY2024, which is 18.50% down from last year.
  • Per Praxis Precision Medicines' latest filing, its Free Cash Flow stood at -$131.8 million for FY2024, which was down 18.50% from -$111.2 million recorded in FY2023.
  • In the past 5 years, Praxis Precision Medicines' Free Cash Flow registered a high of -$52.6 million during FY2020, and its lowest value of -$185.5 million during FY2022.
  • Its 3-year average for Free Cash Flow is -$142.8 million, with a median of -$131.8 million in 2024.
  • As far as peak fluctuations go, Praxis Precision Medicines' Free Cash Flow crashed by 138.67% in 2021, and later skyrocketed by 40.06% in 2023.
  • Praxis Precision Medicines' Free Cash Flow (Yearly) stood at -$52.6 million in 2020, then slumped by 138.67% to -$125.6 million in 2021, then slumped by 47.68% to -$185.5 million in 2022, then soared by 40.06% to -$111.2 million in 2023, then decreased by 18.50% to -$131.8 million in 2024.